证券代码：920300 证券简称：辰光医疗 公告编号：2025-123 上海辰光医疗科技股份有限公司（以下简称"公司"）分别于 2025 年 4 月 23 日、2025 年 5 月 15 日召开第五届董事会第十七次会议、2024 年年度股东会，审 议通过了《关于公司拟续聘中汇会计师事务所（特殊普通合伙）为公司 2025 年 年度审计机构的议案》，同意续聘中汇会计师事务所（特殊普通合伙）（以下简称 "中汇"）为公司 2025 年度审计机构，具体内容详见公司于 2025 年 4 月 25 日在 北京证券交易所官方信息披露平台（www.bse.cn）上披露的《拟续聘 2025 年年 度会计师事务所公告》(公告编号:2025-021)。 2025 年 12 月 8 日，公司收到中汇出具的《关于变更质量控制复核人的告知 函》。 一、本次质量控制复核人变更情况 中汇作为公司 2025 年度审计机构，原委派刘科娜为项目合伙人、曹理彬为 签字注册会计师、何海燕为质量控制复核人为公司提供 2025 年度财务报告审计 及内部控制审计服务。因中汇内部工作调整，现委派于薇薇担任公司 2025 年度 财务报告及内部控制审计质量控制复核 ...

Core Viewpoint - The medical device sector experienced a slight decline of 0.31% on November 6, with Danaher Biomedical leading the losses, while the overall market indices showed gains, with the Shanghai Composite Index up by 0.97% and the Shenzhen Component Index up by 1.73% [1][2]. Group 1: Market Performance - The Shanghai Composite Index closed at 4007.76, increasing by 0.97% [1]. - The Shenzhen Component Index closed at 13452.42, increasing by 1.73% [1]. - The medical device sector saw a net outflow of 638 million yuan from major funds, while retail investors contributed a net inflow of 446 million yuan [2][3]. Group 2: Individual Stock Performance - Hualan Co., Ltd. (301093) saw a significant increase of 8.53%, closing at 44.00 yuan with a trading volume of 67,500 shares and a transaction value of 293 million yuan [1]. - Danaher Biomedical (920009) led the declines with a drop of 4.69%, closing at 83.50 yuan and a trading volume of 24,900 shares, resulting in a transaction value of 206 million yuan [2]. - Other notable gainers included Furuida (300049) with a 4.32% increase and a closing price of 74.56 yuan, and Kangzhong Medical (688607) with a 3.04% increase, closing at 29.81 yuan [1][2]. Group 3: Fund Flow Analysis - Major funds showed a net outflow in several stocks, including Furuida with a net outflow of 23.99 million yuan, while retail investors showed a net inflow of 25.27 million yuan [3]. - Dongfulong (300171) experienced a net inflow of 21.17 million yuan from major funds, indicating positive sentiment towards the stock [3]. - The overall trend indicates a mixed sentiment in the medical device sector, with some stocks attracting retail interest despite the overall outflow from major funds [2][3].

Core Insights - The medical device sector experienced a rise of 1.13% on October 31, with Caina Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 3954.79, down 0.81%, while the Shenzhen Component Index closed at 13378.21, down 1.14% [1] Medical Device Sector Performance - Caina Co., Ltd. (301122) saw a closing price of 30.38, with a significant increase of 19.98% and a trading volume of 91,000 shares, amounting to a transaction value of 259 million [1] - Spring Medical (688236) closed at 28.88, up 14.47%, with a trading volume of 84,200 shares and a transaction value of 235 million [1] - ZhenDe Medical (603301) closed at 95.00, increasing by 9.07% with a trading volume of 211,900 shares, resulting in a transaction value of 1.951 billion [1] - Other notable performers included TuoJing Life (300642) with an 8.81% increase, and Rejing Bio (688068) with an 8.70% increase [1] Capital Flow Analysis - The medical device sector saw a net inflow of 475 million from institutional investors, while retail investors experienced a net outflow of 108 million [2][3] - Major stocks like Mindray Medical (300760) had a net inflow of 262 million from institutional investors, but a net outflow of 1.27 billion from retail investors [3] - Other stocks such as Furuishi (300049) and Lepu Medical (300003) also showed significant net inflows from institutional investors, indicating strong institutional interest [3]

Market Overview - The major indices experienced a decline, with the Shanghai Composite Index down by 0.73% closing at 3986.90, and the Shenzhen Component Index down by 1.16% closing at 13532.13 [9][10] - The overall market saw 1238 companies rise and 4097 companies fall, with a total trading volume of 24642.94 billion, an increase of 1736.2 billion from the previous trading day [10] Economic Insights - The People's Bank of China conducted a 3426 billion 7-day reverse repurchase operation, resulting in a net injection of 1301 billion [23] - The Bank of Japan maintained its benchmark interest rate at 0.5% and raised its GDP growth forecast for the fiscal year 2025 [25] - The Federal Reserve lowered its benchmark interest rate by 25 basis points to a range of 3.75%-4.00% [26] Industry Dynamics - The UK announced the budget and auction rules for AR7, with a total budget of 1.08 billion pounds for clean energy auctions [32] - The logistics sector is seeing innovation with the launch of the first humanoid logistics robot by Hangcha Group, marking a strategic shift towards intelligent logistics solutions [40] Company Performance - Zhongji United (605305.SH) reported a net profit of 438 million for Q3 2025, a year-on-year increase of 84.03% [34] - Dize Pharmaceutical (688192.SH) achieved a revenue of 231 million in Q3 2025, reflecting a growth of 71.46% year-on-year [35] - New Dairy (002946.SZ) reported a revenue growth of 4.42% year-on-year in Q3 2025, with a net profit increase of 27.67% [36] - Tongkun Co., Ltd. (601233.SH) faced a decline in revenue by 11.38% year-on-year for the first three quarters of 2025, but net profit increased by 53.83% [38] - Anker Innovations (300866.SZ) reported a net profit growth of 31.34% year-on-year for the first three quarters of 2025 [47]

证券代码：920300 证券简称：辰光医疗 公告编号：2025-120 上海辰光医疗科技股份有限公司 第五届董事会第二十四次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2025 年 10 月 28 日 2.会议召开地点：上海市青浦区华青路 1269 号 3.会议召开方式：现场会议 4.发出董事会会议通知的时间和方式：2025 年 10 月 23 日以书面、电话和微 信方式发出 5.会议主持人：董事长 王杰 先生 6.会议列席人员：高级管理人员 7.召开情况合法合规的说明： 会议的召集、召开和表决程序符合有关法律、行政法规、规范性文件和《公 司章程》的规定。 （二）会议出席情况 会议应出席董事 9 人，出席和授权出席董事 9 人。 二、议案审议情况 （一）审议通过《2025 年第三季度报告》 1.议案内容： （一）《上海辰光医疗科技股份有限公司第五届董事会第二十四次会议决议》； 根据《北京证券交易所股票上市规则》《北京证券交易 ...

并完成公示的公告 证券代码：920300 证券简称：辰光医疗 公告编号：2025-122 上海辰光医疗科技股份有限公司 关于通过 2025 年专精特新"小巨人"复核 四、备查文件 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、基本情况 根据上海市经济和信息化委员会发布的《关于上海市第七批专精特新"小巨 人"企业和 2025 年专精特新"小巨人"复核通过企业名单的公示》，上海辰光医 疗科技股份有限公司（以下简称"公司"）通过 2025 年专精特新"小巨人"企业复 核。 截至本公告日，公示期已结束。根据《优质中小企业梯度培育管理暂行办法》 （工信部企业〔2022〕63 号），公示无异议的公司，将由国家工业和信息化部认 定为专精特新"小巨人" 企业。 二、对公司的影响 本次公司通过国家级专精特新"小巨人"企业复核，是国家工业和信息化部基 于企业研发技术、创新成果转化能力及企业综合运营情况等多维度评价，对公司 技术水平、创新能力、产品服务综合实力和公司在细分领域取得成果等方面的认 可，有助于公司更好聚焦核 ...

Group 1 - The "14th Five-Year Plan" includes quantum technology as a core future industry, with a focus on quantum computing, communication, and measurement [7][8][10] - By 2025, China's quantum technology market is expected to exceed 20 billion yuan, with a compound annual growth rate of 35%-40% [2][33][35] - The global quantum computing market was valued at 1.1 billion USD in 2022 and is projected to grow to approximately 7.6 billion USD by 2027 [14][16] Group 2 - The median price-to-earnings (P/E) ratio for the information technology sector on the Beijing Stock Exchange increased by 5.26% to 62.4X [43][54] - The median market capitalization for electronic device companies on the Beijing Stock Exchange rose from 2.28 billion yuan to 2.43 billion yuan [45][48] - The median P/E ratio for mechanical equipment companies on the Beijing Stock Exchange increased from 52.5X to 54.4X, with total market capitalization rising from 117.67 billion yuan to 123.18 billion yuan [50][52]

Core Viewpoint - The quantum technology sector has recently shown strong performance, with significant stock price increases observed on October 29, particularly in companies like Shenzhou Information and Keda Guokuan [1]. Group 1: Stock Performance - Shenzhou Information reached a limit-up, while Keda Guokuan surged over 19% [1]. - Other notable performers included GuoDun Quantum, which hit a new high, and companies like Western Superconducting, XinAn Century, and Fujida also saw gains [1]. - The following table summarizes the stock performance of key companies in the quantum technology sector: | Code | Name | Change (%) | Current Price | |--------|--------------|------------|----------------| | 300520 | Keda Guokuan | +19.38% | 44.29 | | 688027 | GuoDun Quantum| +12.10% | 515.67 | | 688122 | Western Superconducting | +10.35% | 88.03 | | 002212 | Tianrongxin | +10.02% | 10.76 | | 000255 | Shenzhou Information | +9.99% | 16.73 | | 920640 | Fujida | +10.81% | 32.50 | | 688622 | Hexin Instruments | +7.19% | 136.68 | | 688337 | Puyuan Precision | +6.11% | 41.70 | | 002512 | Dahua Intelligent | +4.81% | 5.66 | | 920300 | Chenguang Medical | +6.13% | 18.18 | | 688201 | XinAn Century | +5.27% | 15.77 | | 300768 | Dipu Technology | +5.07% | 24.47 | | 603232 | Geer Software | +4.46% | 23.20 | | 300555 | ST Lutong | +4.41% | 12.07 | | 003029 | Jida Zhengyuan | +5.22% | 28.42 [2] Group 2: Technological Developments - On October 28, NVIDIA officially launched the NVQLink interconnection system, which connects quantum processors with the AI supercomputers necessary for their efficient operation [3]. - Huang Renxun described NVQLink as the Rosetta Stone for connecting quantum and classical supercomputers [3].

Core Insights - The medical device sector experienced a slight increase of 0.37% on October 24, with Mai Lande leading the gains [1] - The Shanghai Composite Index closed at 3950.31, up 0.71%, while the Shenzhen Component Index closed at 13289.18, up 2.02% [1] Medical Device Sector Performance - Top gainers included: - Mai Lande (688273) with a closing price of 41.92, up 6.31%, trading volume of 29,300 hands, and a transaction value of 121 million yuan [1] - Xiangyu Medical (688626) at 53.21, up 6.10%, with a trading volume of 41,100 hands and a transaction value of 216 million yuan [1] - Xiangsheng Medical (688358) at 35.27, up 4.75%, with a trading volume of 38,400 hands and a transaction value of 136 million yuan [1] - Other notable gainers included: - Aohua Endoscopy (688212) at 50.59, up 4.74%, with a transaction value of 225 million yuan [1] - Weisi Medical (688580) at 49.10, up 4.71%, with a transaction value of approximately 99.8 million yuan [1] Decliners in Medical Device Sector - Notable decliners included: - Chenguang Medical (920300) at 17.51, down 8.80%, with a trading volume of 124,000 hands [2] - Toukeng Life (300642) at 22.95, down 5.40%, with a trading volume of 175,700 hands [2] - Haitai New Light (688677) at 48.50, down 5.05%, with a trading volume of 38,800 hands [2] - Other significant decliners included: - Sino Medical (688108) at 28.00, down 4.73%, with a trading volume of 263,700 hands [2] - Tianchen Medical (688013) at 55.66, down 3.98%, with a trading volume of 19,200 hands [2] Capital Flow in Medical Device Sector - The medical device sector saw a net outflow of 654 million yuan from major funds, while retail investors contributed a net inflow of 455 million yuan [2]

Market Overview - The A-share market opened lower on October 23, with the Shanghai Composite Index maintaining above 3900 points and the Shenzhen Component regaining 13000 points in the afternoon. The market turnover fell to 1.66 trillion yuan, marking a new low in two and a half months [4]. Sector Performance - Energy, near-term new stocks, film and television, and quantum technology sectors saw significant gains, while cultivated diamonds, glass fiber, communication equipment, and engineering machinery sectors experienced declines. Quantum technology stocks surged in the last trading minutes, with Keda Guokuan (300520) hitting a 20% limit up [5]. Key Developments - On October 22, Google announced a new algorithm named "Quantum Echo" developed by its quantum computing research team, which can compute molecular structures 13,000 times faster than the best supercomputers [8]. - Major inflows of over 3.2 billion yuan were observed in non-ferrous metals, with coal, media, basic chemicals, and non-bank financials also receiving over 2 billion yuan each. However, the electronics sector saw a net outflow exceeding 6.7 billion yuan [8]. Future Outlook - According to Debon Securities, the reduced trading volume indicates cautious market sentiment, with financial and energy sectors providing support. The focus may shift to the "14th Five-Year Plan" policies, particularly in expanding domestic demand and consumer sectors [9]. - Huajin Securities anticipates that the implementation of the "14th Five-Year Plan" will strengthen the technology sector, benefiting industries such as electronics and robotics, as well as innovative pharmaceuticals and green energy sectors [9]. Company Earnings - Several new stocks reported strong growth in their Q3 earnings. Guangdong Jianke turned a profit in the first three quarters of 2025, while Aifenda reported a net profit of 96.41 million yuan, a year-on-year increase of 11.71% [11]. - Jianfa Zhixin expects a net profit of 200 to 222 million yuan for the first three quarters of 2025, a growth of 30% to 40%, with Q3 results to be disclosed on October 28 [11].